Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors
Open Access
- 1 April 2001
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 14 (4) , 267-272
- https://doi.org/10.1038/modpathol.3880300
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- THE APPLICATION OF HUMAN COMPLEMENT FACTOR H-RELATED PROTEIN (BTA TRAK) IN MONITORING PATIENTS WITH BLADDER CANCERUrologic Clinics of North America, 2000
- THE NATURAL HISTORY OF BLADDER CANCERUrologic Clinics of North America, 2000
- URINE CYTOLOGY: Is it Still the Gold Standard for Screening?Urologic Clinics of North America, 2000
- Identical clonal origin of synchronous and metachronous low-grade, noninvasive papillary transitional cell carcinomas of the urinary tractHuman Pathology, 1999
- RECURRENCE AND PROGRESSION IN LOW GRADE PAPILLARY UROTHELIAL TUMORSJournal of Urology, 1999
- Expression of cytokeratin 20 redefines urothelial papillomas of the bladderThe Lancet, 1999
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderThe American Journal of Surgical Pathology, 1998
- Cytokeratin 20 as an objective marker of urothelial dysplasiaBritish Journal of Urology, 1996
- Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent diseaseHistopathology, 1995
- Identification of p53 Gene Mutations in Bladder Cancers and Urine SamplesScience, 1991